Story

The FDA has approved updated COVID-19 vaccines for the 2025-2026 season, with stricter eligibility rules focusing on older adults and high-risk individuals. Pfizer-BioNTech's shot is for those 65 and older and high-risk individuals aged 5-64, while Moderna's is for high-risk groups 6 months and older, and Novavax is for those 12 and up.

from Times of India https://ift.tt/o4kxb1A